Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Yuyao Biotech logo — Advancing healthcare with innovative AI-driven solutions for...

Yuyao Biotech

Advancing healthcare with innovative AI-driven solutions for hematological tumors, neurodegenerative, and autoimmune diseases.

Founded 2020 Seed Total: $90.00M Biopharma, Biotechnology

General Information

Company Name Yuyao Biotech
Founded Year 2020
Industries Biopharma, Biotechnology
Funding Stage Seed
Social

Get notified when Yuyao Biotech moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Yuyao Biotech

Yuyao Biotech, a biotechnology company founded in 2020, is making strides in healthcare with its innovative AI-driven solutions for hematological tumors, neurodegenerative, and autoimmune diseases. The company's commitment to addressing major unmet clinical drug needs is evident through its integration of artificial intelligence and advanced drug creation technology. Their last investment of CNY90.00M in a Seed Round at 30 December 2022 was backed by LC Ventures, Mingyu Capital, and Intertek Industries. Yuyao Biotech's focus on biopharma and biotechnology industries showcases its dedication to innovation for the betterment of human health.

Taxonomy: Drug Development, Healthcare Innovation, Hematological Tumors, Neurodegenerative Diseases, Autoimmune Diseases, Clinical Drug Needs, Innovative Solutions, Human Health, Technology Integration, Modern Drug Creation, Startup, Investment Potential

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 3
Investor
•••• •••• 		30 Dec 2022

Yuyao Biotech Alternatives & Competitors

Yuyao Biotech vs
NewBiotics
NewBiotics

Turning drug resistance into therapeutic breakthroughs, pioneering drug molecules for cancer and inf...

Series E
Health Care, Health and Wellness
Yuyao Biotech vs
INVENT Pharmaceuticals
INVENT Pharmaceuticals United States

Transforming molecules to medicines

1 employees
Biotechnology, Health Care
Yuyao Biotech vs
PYC Therapeutics (ASX: PYC)
PYC Therapeutics (ASX: PYC) United States

Pioneering a new generation of RNA therapeutics to change the lives of patients with severe inherite...

IPO
66 employees
Biotechnology

FAQ About Yuyao Biotech

Advancing healthcare with innovative AI-driven solutions for hematological tumors, neurodegenerative, and autoimmune diseases.
Yuyao Biotech was founded in 2020.
Yuyao Biotech operates in the following industries: Biopharma, Biotechnology.
Yuyao Biotech has completed 1 funding round, raising a total of $90.00M. The latest funding stage is Seed.
Top alternatives and competitors to Yuyao Biotech include NewBiotics, INVENT Pharmaceuticals, PYC Therapeutics (ASX: PYC), Delpor, Inc., Danking Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Yuyao Biotech and NewBiotics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Yuyao Biotech and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy